Skip to content

Thermoregulatory Physiology of Menopausal Hot Flashes

Thermoregulatory Physiology of Menopausal Hot Flashes

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07824648
Enrollment
40
Registered
2026-09-17
Start date
2026-05-05
Completion date
2027-09-15
Last updated
2026-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Menopause Hot Flashes

Brief summary

This study is evaluating the effects of cooling on menopausal hot flashes in midlife women. Precise targeted cooling is provided to areas of the skin when a hot flash occurs.

Interventions

OTHERIntervention C (Targeted skin cooling)

Cooling targeted to the skin during a hot flash

OTHERIntervention B (Ambient cooling)

Cooling of the room

OTHERIntervention A (Room temperature)

Control condition (room temperature)

Sponsors

SRI International
Lead SponsorINDUSTRY
National Institute on Aging (NIA)
CollaboratorNIH
Stanford University
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

There are three temperature interventions, each participant may be exposed to during the study: room temperature, ambient cooling, targeted skin cooling

Eligibility

Sex/Gender
FEMALE
Age
40 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Female * Age range: 40 to 65 years and in menopausal transition or post-menopause; * At least 8 years of education to ensure adequate reading proficiency; * Primary language is English or Spanish.

Exclusion criteria

* History of medical or neurological illness or trauma that would affect the central nervous system (e.g., stroke, multiple sclerosis, epilepsy); * Current severe medical conditions (e.g. Diabetes, cancer, cardiovascular disease, renal or hepatic disease, thyroid disorders); * History of schizophrenia and/or bipolar disorder; * Dependence or abuse of illicit substances in the past year; * Current use of hormone therapy or other treatments for hot flash symptoms

Design outcomes

Primary

MeasureTime frameDescription
Number of hot flashesAcross the ~5 hour experimental period in the labNumber of hot flashes, based on sternal skin conductance measurement

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 18, 2026